Literature DB >> 21269667

A nomogram for estimating the probability of ovarian cancer.

Jason A Lachance1, Asim F Choudhri, Marc Sarti, Susan C Modesitt, Amir A Jazaeri, George J Stukenborg.   

Abstract

OBJECTIVE: Accurate preoperative estimates of the probability of malignancy in women with adnexal masses are essential for ensuring optimal care. This study presents a new statistical model for combining predictive information and a graphic decision support tool for calculating risk of malignancy.
METHODS: The study included 153 women treated with definitive surgery for adnexal mass between 2001 and 2007 with preoperative ultrasound testing and a serum CA125. Multivariable logistic regression was used to develop a statistical model for estimating the probability of ovarian cancer as a function of age, ultrasound score, and CA125 value, with adjustments for nonlinear and interactive relationships.
RESULTS: A total of 20 cases of pathologically confirmed cancer (13 invasive malignancies, and 7 tumors of low malignant potential) were identified (20/153=13%). The model obtained excellent discrimination (ROC area=0.87), explained nearly half of the observed variation in the risk of malignancy (R²=0.43), and was well calibrated across the full range of malignancy probabilities. The model equation is represented in the form of a nomogram, which can be used to calculate preoperative probability of malignancy. At a 5% risk of malignancy threshold, the model has a sensitivity of 90% and a specificity of 73%.
CONCLUSIONS: Statistical models for estimating the probability of adnexal mass malignancy are substantially improved by including adjustments for non-linear relationships among key variables. A clinically relevant nomogram provides an objective tool to further aid clinicians in counseling patients and ensuring proper referral to surgical sub-specialists when indicated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269667     DOI: 10.1016/j.ygyno.2010.12.365

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.

Authors:  Onur Turkoglu; Amna Zeb; Stewart Graham; Thomas Szyperski; J Brian Szender; Kunle Odunsi; Ray Bahado-Singh
Journal:  Metabolomics       Date:  2016-03-08       Impact factor: 4.290

2.  Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.

Authors:  Fanny Dao; Brooke A Schlappe; Jill Tseng; Jenny Lester; Alpa M Nick; Susan K Lutgendorf; Scott McMeekin; Robert L Coleman; Kathleen N Moore; Beth Y Karlan; Anil K Sood; Douglas A Levine
Journal:  Gynecol Oncol       Date:  2016-03-11       Impact factor: 5.482

3.  Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.

Authors:  Irene A Burger; Debra A Goldman; Hebert Alberto Vargas; Michael W Kattan; Changhon Yu; Lei Kou; Vaagn Andikyan; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Gynecol Oncol       Date:  2015-06-17       Impact factor: 5.482

4.  A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.

Authors:  Xue-Lian Xu; Hao Cheng; Meng-Si Tang; Hai-Liang Zhang; Rui-Yan Wu; Yan Yu; Xuan Li; Xiu-Min Wang; Jia Mai; Chen-Lu Yang; Lin Jiao; Zhi-Ling Li; Zhen-Mei Zhong; Rong Deng; Jun-Dong Li; Xiao-Feng Zhu
Journal:  Oncotarget       Date:  2017-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.